Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
ISHITADR •BSE
Ishita Drugs & Industries
₹72.902.02 (2.85%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events
Performance
Today’s low
72.90
Today’s high
73.80
52 week low
66.00
52 week high
90.85
Open price
73.80
Previous close
70.88
Live volume
1,026
Lower circuit
56.71
Upper circuit
85.05
Fundamentals
Market Cap
₹21Cr
ROE
6.73%
P/E Ratio(TTM)
30.03
EPS(TTM)
2.36
P/B Ratio
1.83
Dividend Yield
0.00%
Industry P/E
51.21
Book Value
38.69
Debt to Equity
0.01
Face Value
10
Financial performance
JUN '26
Revenue (Cr)
₹3.19
-2.74%
Profit (Cr)
₹0.23
+27.78%
01.534.56
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
| Revenue growth | Value |
|---|---|
| 1Y (TTM) | -42% |
| 3Y CAGR | +7.0% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | -23% |
| 3Y CAGR | +10% |
About
Ishita Drugs & Industries Ltd. is an established company that manufactures Active Pharma Ingredients (APIs) and various drug intermediates. The company’s philosophy is to uphold the highest ethical standards and good corporate governance to ensure investor interests are protected. It has built a strong reputation as a maker of high-quality products and is well-regarded for its ethical business dealings. Its principal business, contributing to 100% of its turnover, is the manufacture of bulk drugs, fine chemicals, and intermediates. The company serves leading pharmaceutical firms in India and exports globally, with export revenue showing significant growth in the past year. The company achieved its highest-ever total revenue, which increased by 26.03% to ₹1546.78 lakh during the year under review.;
CEO/MD
Mr. Jagdish Agrawal
Founded in
1992
BSE symbol
524400
Shareholding pattern
Similar stocks
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,810.80 -34.20 (1.20%) | 21,608.60 | 31.87 | 6.03 | ||
PfizerPFIZER | ₹4,609.70 -34.00 (0.73%) | 21,256.23 | 28.91 | 5.06 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,944.00 +3.50 (0.05%) | 17,367.38 | 102.39 | 19.9 | ||
Marksans PharmaMARKSANS | ₹326.75 -5.45 (1.64%) | 15,035.97 | 28.85 | 4.97 |
2026
8
Aug
Quarterly Result
Release date
30
May
Annual Result
Release date
7
Feb
Quarterly Result
Release date
2025
11
Nov
Quarterly Result
Release date
12
Aug
Quarterly Result
Release date
Events calendar
View upcoming events in other stocks